Find your path to Martin
204 people in our graph share verified history with Martin — schools, employers, funds. One of them is your warm intro.
Marta CruzunlockedMartin: together at University of Buenos Aires (1994–1997)
×7Martin: together at University of Buenos Aires
×3Martin: together at Universidad del Salvador
Martin: together at Universidad Austral, Buenos Aires
Chief Development Officer at Phoenix Molecular Designs
Intro paths
→
In turn, Martin can intro founders to Phoenix Molecular Designs's investors below.
Phoenix Molecular Designs's investors · 3
Co-founders at Phoenix Molecular Designs
SD
Sandra DunnFounder
Experience
- Phrontline BiopharmaChief Medical Officercurrent2025 — presentShanghai, China
- Oncology Innovations LLCOwnercurrent2025 — presentNew Jersey, United States
- Radiance BiopharmaChief Medical Officer2024 — 2025Boston, Massachusetts, United States
- Phoenix Molecular DesignsScientific Advisor2022 — 2025
- SystImmuneChief Medical Officer2022 — 2024Redmond, Washington, United States
- Protara TherapeuticsChief Medical Officer2021New York City Metropolitan Area
- ImmunomedicsVice President Clinical Development. Breast Cancer Lead.2018 — 2021New York City Metropolitan Area
- Daiichi Sankyo, Inc.Executive Director, Global Oncology R&D2017 — 2018Basking Ridge, New Jersey
- Eisai USInternational Program Team Leader for Halaven and Eribulin LF2016 — 2017
- EisaiSr. Director, Global Clinical Lead - Breast Cancer2013 — 2016
- EisaiDirector, Clinical Research Oncology2011 — 2013
- CelgeneAssociate Director, Clinical Development2009 — 2011
- Canadian Cancer Trials GroupInvestigational New Drugs Fellowship2008 — 2009
- Hospital Enrique TornuStaff Oncology Physician and Sub Investiagtor2006 — 2008
- Hospital Enrique TornuClincal Research Manager. Oncology Division2003 — 2008
Skills & more
Drug DevelopmentBusiness DevelopmentMedical AffairsOncologyClinical TrialsClinical ResearchDrug DiscoveryClinical Trial ManagementProtocol DevelopmentClinical MonitoringClinical Development
Languages English · Spanish
From Martin's professional profile.
Frequently asked questions
- Who is Martin S. Olivo?
- Chief Development Officer at Phoenix Molecular Designs
- Where does Martin S. Olivo work?
- Martin S. Olivo is Chief Development Officer at Phoenix Molecular Designs.
- Where did Martin S. Olivo go to school?
- Martin S. Olivo studied at University of Buenos Aires (Medical Doctor, Physician); Universidad del Salvador (Oncology Specialist, Oncology and Cancer Biology); Universidad Austral, Buenos Aires (Master, Clinical and Pharmacological Research).
Same school
Also attended University of Buenos Aires174
Arturo LitvinHead of Global Portfolio Development at Intel CapitalJonas VetterleInvestor at Moonfire VenturesCameron McLainBuilding things that endure, and living fully along the way.Marta CruzCo-Founder and Managing Partner of NXTP VenturesEduardo RazzettiChief Financial Officer at NXTPAgustina ChaarAccounting and Treasury Analyst at NXTP
+ 168 more
Also attended Universidad del Salvador16
RobertPartner at Maven Ventures focused on AI, fintech, and longevityElie VacquéJunior Financial Controller at EducapitalVictoria AkermanPrincipal - Portfolio Management & Investor Relations at Newtopia VCJuan Pablo LafosseCo-founder & General Partner at Newtopia VCBecca ShmuklerPrincipal at Laerdal Million Lives FundTeresita di MarcoPrincipal at The Yield Lab Latam
+ 10 more
Also attended Universidad Austral, Buenos Aires29
Miguel ParanhosGrowth Investor at Five Elms CapitalMariano MayerCo-founder & Managing Partner at Newtopia VCJuan CabreraGeneral Partner at Xperiment VenturesJokūbas KarnauskasAssociate at BSV VenturesTomás PeñaManaging Partner at The Yield Lab LatamTeresita di MarcoPrincipal at The Yield Lab Latam
+ 23 more
